***NON-POLITICAL COVID-19 Discussion Thread***

[JakeF]

A couple of reminders...

Originally Posted by Bwana

Once again, don't come in this thread with some kind of political agenda, or you will be shown the door. If you want to go that route, there is a thread about this in DC.

Originally Posted by Dartgod

People, there is a lot of good information in this thread, let's try to keep the petty bickering to a minimum.

We all have varying opinions about the impact of this, the numbers, etc. We will all never agree with each other. But we can all keep it civil.

Thanks!

Click here for the original OP:

Spoiler!

Apparently the CoronaVirus can survive on a inanimate objects, such as door knobs, for 9 days.

California coronavirus case could be first spread within U.S. community, CDC says
By SOUMYA KARLAMANGLA, JACLYN COSGROVE
FEB. 26, 2020 8:04 PM

The Centers for Disease Control and Prevention is investigating what could be the first case of novel coronavirus in the United States involving a patient in California who neither recently traveled out of the country nor was in contact with someone who did.

“At this time, the patient’s exposure is unknown. It’s possible this could be an instance of community spread of COVID-19, which would be the first time this has happened in the United States,” the CDC said in a statement. “Community spread means spread of an illness for which the source of infection is unknown. It’s also possible, however, that the patient may have been exposed to a returned traveler who was infected.”

The individual is a resident of Solano County and is receiving medical care in Sacramento County, according to the state Department of Public Health.

The CDC said the “case was detected through the U.S. public health system — picked up by astute clinicians.”

Officials at UC Davis Medical Center expanded on what the federal agency might have meant by that in an email sent Wednesday, as reported by the Davis Enterprise newspaper.

The patient arrived at UC Davis Medical Center from another hospital Feb. 19 and “had already been intubated, was on a ventilator, and given droplet protection orders because of an undiagnosed and suspected viral condition,” according to an email sent by UC Davis officials that was obtained by the Davis Enterprise.

The staff at UC Davis requested COVID-19 testing by the CDC, but because the patient didn’t fit the CDC’s existing criteria for the virus, a test wasn’t immediately administered, according to the email. The CDC then ordered the test Sunday, and results were announced Wednesday. Hospital administrators reportedly said in the email that despite these issues, there has been minimal exposure at the hospital because of safety protocols they have in place.

A UC Davis Health spokesperson declined Wednesday evening to share the email with The Times.

Since Feb. 2, more than 8,400 returning travelers from China have entered California, according to the state health department. They have been advised to self-quarantine for 14 days and limit interactions with others as much as possible, officials said.

“This is a new virus, and while we are still learning about it, there is a lot we already know,” Dr. Sonia Angell, director of the California Department of Public Health, said in a statement. “We have been anticipating the potential for such a case in the U.S., and given our close familial, social and business relationships with China, it is not unexpected that the first case in the U.S. would be in California.”

It is not clear how the person became infected, but public health workers could not identify any contacts with people who had traveled to China or other areas where the virus is widespread. That raises concern that the virus is spreading in the United States, creating a challenge for public health officials, experts say.

“It’s the first signal that we could be having silent transmission in the community,” said Lawrence Gostin, director of the World Health Organization Collaborating Center on National and Global Health Law. “It probably means there are many more cases out there, and it probably means this individual has infected others, and now it’s a race to try to find out who that person has infected.”

On Tuesday, the CDC offered its most serious warning to date that the United States should expect and prepare for the coronavirus to become a more widespread health issue.

“Ultimately, we expect we will see coronavirus spread in this country,” said Nancy Messonnier, director of the CDC’s National Center for Immunization and Respiratory Diseases. “It’s not so much a question of if, but a question of when.”

According to the CDC’s latest count Wednesday morning, 59 U.S. residents have tested positive for the new strain of coronavirus — 42 of whom are repatriated citizens from a Diamond Princess cruise. That number has grown by two since Messonnier’s last count Tuesday, although the CDC was not immediately available to offer details on the additional cases.

More than 82,000 cases of coronavirus have been reported globally, and more than 2,700 people have died, with the majority in mainland China, the epicenter of the outbreak.

But public health leaders have repeatedly reminded residents that the health risk from the novel coronavirus to the general public remains low.

“While COVID-19 has a high transmission rate, it has a low mortality rate,” the state Department of Public Health said in a statement Wednesday. “From the international data we have, of those who have tested positive for COVID-19, approximately 80% do not exhibit symptoms that would require hospitalization. There have been no confirmed deaths related to COVID-19 in the United States to date.”

CDC officials have also warned that although the virus is likely to spread in U.S. communities, the flu still poses a greater risk.

Gostin said the news of potential silent transmission does not eliminate the possibility of containing the virus in the U.S. and preventing an outbreak.

“There are few enough cases that we should at least try,” he said. “Most of us are not optimistic that that will be successful, but we’re still in the position to try.”

[BleedingRed]

Originally Posted by DaFace

It's hard to understand how they could claim a "cure" without all the trials, but...sure...fingers crossed.

Read it then,

Through further testing, the researchers at Sorrento found that there was one particular antibody that showed to be 100 percent effective in blocking COVID-19 from infecting health cells — STI-1499.

[Monticore]

Originally Posted by Donger

100%? Wow, if true.

The only thing that is 100% guaranteed is the fact we will be arguing about this for the next few days.

[DaFace]

Originally Posted by BleedingRed

Read it then,

Through further testing, the researchers at Sorrento found that there was one particular antibody that showed to be 100 percent effective in blocking COVID-19 from infecting health cells — STI-1499.

Maybe it's that simple - I don't know. It just sounds like all they've done is lab tests, which don't always translate.

[Strongside]

In the interview he says the antibodies essentially wrap around COVID like a jacket. They have seen COVID completely eliminated from test cells in no more than 4 days.

So, yeah. If it translates beyond the lab, football's back on the menu.

[DaFace]

Anyone have a WSJ subscription? I'm curious to review their (skeptical) take:

https://www.wsj.com/articles/be-100-...re-11589564968

[BleedingRed]

Originally Posted by Strongside

In the interview he says the antibodies essentially wrap around COVID like a jacket. They have seen COVID completely eliminated from test cells in no more than 4 days.

So, yeah. If it translates beyond the lab, football's back on the menu.

if anything its another wep to fight COVID with.

[BleedingRed]

Originally Posted by DaFace

Anyone have a WSJ subscription? I'm curious to review their (skeptical) take:

https://www.wsj.com/articles/be-100-...re-11589564968

I don't but man if you claim you have a cure, and it turns out you lied... Bro you might be thrown in jail for the rest of your life XD

I'm sure there is a law on the books somewhere.

[Donger]

In preclinical testing of cells, Sorrento's antibody drug provided "100% inhibition" of SARS-CoV-2 — the new coronavirus that causes Covid-19 — within four days. Sorrento expects this antibody to be the first in a drug cocktail that would create a "protective shield" against infection.

But Sorrento is far from the only company working on an antibody-based approach to a coronavirus treatment. Bigger players like Eli Lilly (LLY) and Regeneron Pharmaceuticals (REGN) also have programs in this arena.

Further, Sorrento has only so far conducted testing in cells. In order to eventually gain Food and Drug Administration approval, Sorrento will need to test its coronavirus treatment in animals. Then, it will have to ask the FDA for permission to begin testing for safety and effectiveness in humans.

"It's just hype," Brad Loncar, Chief Executive of Loncar Investments, said in an email. Loncar provides the index for two exchange-traded funds that track biotech companies. "There are many companies working on antibodies that are far ahead."

Still, shares of Sorrento charged up 157%, near 6.70, in afternoon trading on the stock market today. Sorrento representatives didn't immediately return a request for comment.

[Monticore]

For the stats people

Our district has done 4600 tests 20 positive 1 dead ( 50 female)

[ChiliConCarnage]

Originally Posted by DaFace

Anyone have a WSJ subscription? I'm curious to review their (skeptical) take:

https://www.wsj.com/articles/be-100-...re-11589564968

http://archive.is/V0C8F

[DaFace]

Originally Posted by ChiliConCarnage

http://archive.is/V0C8F

Well, that was disappointing (not helpful). Thanks though!

[TLO]

So is this one of those stories like the doctor prescribing hydroxycloriquine in New York with a 100% success rate?

[BleedingRed]

Originally Posted by Donger

In preclinical testing of cells, Sorrento's antibody drug provided "100% inhibition" of SARS-CoV-2 — the new coronavirus that causes Covid-19 — within four days. Sorrento expects this antibody to be the first in a drug cocktail that would create a "protective shield" against infection.

But Sorrento is far from the only company working on an antibody-based approach to a coronavirus treatment. Bigger players like Eli Lilly (LLY) and Regeneron Pharmaceuticals (REGN) also have programs in this arena.

Further, Sorrento has only so far conducted testing in cells. In order to eventually gain Food and Drug Administration approval, Sorrento will need to test its coronavirus treatment in animals. Then, it will have to ask the FDA for permission to begin testing for safety and effectiveness in humans.

"It's just hype," Brad Loncar, Chief Executive of Loncar Investments, said in an email. Loncar provides the index for two exchange-traded funds that track biotech companies. "There are many companies working on antibodies that are far ahead."

Still, shares of Sorrento charged up 157%, near 6.70, in afternoon trading on the stock market today. Sorrento representatives didn't immediately return a request for comment.

that being said they are he first to say anything positive like this. Maybe because they are smaller they have less risk. Or maybe because they were first.

Who knows.

[Monticore]

Originally Posted by BleedingRed

that being said they are he first to say anything positive like this. Maybe because they are smaller they have less risk. Or maybe because they were first.

Who knows.

Because most companies normally want further testing before proclaiming a 100% cure. You just went through this with HCQ remember those 100% claims

[Titty Meat]

The outbreak is at Lee's Summit Pointe Health and Rehabilitation. At least 13 people have been infected.